Maravai LifeSciences MRVI
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 3.25 | 212 | -15.59 | -36 | -4.41 | 771 |
| 2025Q3 | 2.87 | 245 | -10.00 | -26 | -2.93 | 849 |
| 2025Q2 | 2.41 | 266 | -13.98 | -40 | -4.26 | 897 |
| 2025Q1 | 2.21 | 301 | -9.57 | -30 | -3.04 | 960 |
| 2024Q4 | 5.45 | 325 | -7.73 | -26 | -2.27 | 1,008 |
| 2024Q3 | 8.31 | 345 | -25.33 | -99 | -7.27 | 1,278 |
| 2024Q2 | 7.16 | 437 | -1.79 | -8 | -0.52 | 1,448 |
| 2024Q1 | 8.67 | 411 | -2.92 | -12 | -0.82 | 1,445 |
| 2023Q4 | 6.55 | 417 | -22.64 | -106 | -5.64 | 1,487 |
| 2023Q3 | 10.00 | 519 | -1.24 | -6 | -0.29 | 2,268 |
| 2023Q2 | 12.43 | 521 | -1.26 | -7 | -0.29 | 2,264 |
| 2023Q1 | 14.01 | 522 | -0.01 | 0 | 0.00 | 2,315 |
| 2022Q4 | 14.31 | 545 | 7.18 | 38 | 1.66 | 2,282 |
| 2022Q3 | 25.53 | 504 | 9.26 | 44 | 2.01 | 2,249 |
| 2022Q2 | 28.41 | 457 | 16.98 | 71 | 3.38 | 2,172 |
| 2022Q1 | 35.27 | 383 | 19.16 | 67 | 3.38 | 2,043 |
| 2021Q4 | 41.90 | 315 | 18.06 | 56 | 2.93 | 1,918 |
| 2021Q3 | 49.08 | 303 | 21.89 | 54 | 3.11 | 1,895 |
| 2021Q2 | 41.73 | 194 | 32.11 | 49 | 3.33 | 1,601 |
| 2021Q1 | 35.64 | 113 | 17.39 | 23 | 1.77 | 1,352 |